LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Thesis ; Online: Systems analysis of the physiological landscape of antibody repertoires following immunization

    Csepregi, Lucia

    2021  

    Keywords info:eu-repo/classification/ddc/570 ; Life sciences
    Language English
    Publisher ETH Zurich
    Publishing country ch
    Document type Thesis ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.

    Krolik, Michal / Csepregi, Lucia / Hartmann, Fabienne / Engetschwiler, Céline / Flatz, Lukas

    Vaccine

    2021  Volume 39, Issue 8, Page(s) 1257–1264

    Abstract: Reverse genetically engineered recombinant lymphocytic choriomeningitis virus (rLCMV) is a novel vaccine vector platform. Here, we investigate the safety and efficacy of rLCMV in mice lacking a functional type I interferon system with high susceptibility ...

    Abstract Reverse genetically engineered recombinant lymphocytic choriomeningitis virus (rLCMV) is a novel vaccine vector platform. Here, we investigate the safety and efficacy of rLCMV in mice lacking a functional type I interferon system with high susceptibility to viral infections. Propagation-deficient rLCMV vector expressing ovalbumin as a model antigen is cleared from type I interferon receptor-deficient mice (Ifnar
    MeSH term(s) Animals ; CD8-Positive T-Lymphocytes ; Lymphocytic choriomeningitis virus ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Receptor, Interferon alpha-beta/genetics ; Vaccines, Synthetic/genetics ; Viral Vaccines
    Chemical Substances Vaccines, Synthetic ; Viral Vaccines ; Receptor, Interferon alpha-beta (156986-95-7)
    Language English
    Publishing date 2021-01-29
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2021.01.047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Synthetic and Systems Immunology Conference in Ascona, Switzerland.

    Csepregi, Lucia / Neumeier, Daniel / Reddy, Sai T

    European journal of immunology

    2019  Volume 49, Issue 7, Page(s) 980–981

    Language English
    Publishing date 2019-07-02
    Publishing country Germany
    Document type News ; Research Support, Non-U.S. Gov't
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.201970075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Immune Literacy: Reading, Writing, and Editing Adaptive Immunity.

    Csepregi, Lucia / Ehling, Roy A / Wagner, Bastian / Reddy, Sai T

    iScience

    2020  Volume 23, Issue 9, Page(s) 101519

    Abstract: Advances in reading, writing, and editing DNA are providing unprecedented insights into the complexity of immunological systems. This combination of systems and synthetic biology methods is enabling the quantitative and precise understanding of molecular ...

    Abstract Advances in reading, writing, and editing DNA are providing unprecedented insights into the complexity of immunological systems. This combination of systems and synthetic biology methods is enabling the quantitative and precise understanding of molecular recognition in adaptive immunity, thus providing a framework for reprogramming immune responses for translational medicine. In this review, we will highlight state-of-the-art methods such as immune repertoire sequencing, immunoinformatics, and immunogenomic engineering and their application toward adaptive immunity. We showcase novel and interdisciplinary approaches that have the promise of transforming the design and breadth of molecular and cellular immunotherapies.
    Keywords covid19
    Language English
    Publishing date 2020-09-01
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2020.101519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells.

    Neumeier, Daniel / Yermanos, Alexander / Agrafiotis, Andreas / Csepregi, Lucia / Chowdhury, Tasnia / Ehling, Roy A / Kuhn, Raphael / Cotet, Tudor-Stefan / Brisset-Di Roberto, Raphaël / Di Tacchio, Mariangela / Antonialli, Renan / Starkie, Dale / Lightwood, Daniel J / Oxenius, Annette / Reddy, Sai T

    Proceedings of the National Academy of Sciences of the United States of America

    2022  Volume 119, Issue 18, Page(s) e2113766119

    Abstract: The capacity of humoral B cell-mediated immunity to effectively respond to and protect against pathogenic infections is largely driven by the presence of a diverse repertoire of polyclonal antibodies in the serum, which are produced by plasma cells (PCs). ...

    Abstract The capacity of humoral B cell-mediated immunity to effectively respond to and protect against pathogenic infections is largely driven by the presence of a diverse repertoire of polyclonal antibodies in the serum, which are produced by plasma cells (PCs). Recent studies have started to reveal the balance between deterministic mechanisms and stochasticity of antibody repertoires on a genotypic level (i.e., clonal diversity, somatic hypermutation, and germline gene usage). However, it remains unclear if clonal selection and expansion of PCs follow any deterministic rules or are stochastic with regards to phenotypic antibody properties (i.e., antigen-binding, affinity, and epitope specificity). Here, we report on the in-depth genotypic and phenotypic characterization of clonally expanded PC antibody repertoires following protein immunization. We find that clonal expansion drives antigen specificity of the most expanded clones (top ∼10), whereas among the rest of the clonal repertoire antigen specificity is stochastic. Furthermore, we report both on a polyclonal repertoire and clonal lineage level that antibody-antigen binding affinity does not correlate with clonal expansion or somatic hypermutation. Last, we provide evidence for convergence toward targeting dominant epitopes despite clonal sequence diversity among the most expanded clones. Our results highlight the extent to which clonal expansion can be ascribed to antigen binding, affinity, and epitope specificity, and they have implications for the assessment of effective vaccines.
    MeSH term(s) Animals ; Antibodies/genetics ; Antibody Affinity ; Antigens ; Epitopes/genetics ; Mice ; Plasma Cells
    Chemical Substances Antibodies ; Antigens ; Epitopes
    Language English
    Publishing date 2022-04-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2113766119
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Molecular Design, Optimization, and Genomic Integration of Chimeric B Cell Receptors in Murine B Cells.

    Pesch, Theresa / Bonati, Lucia / Kelton, William / Parola, Cristina / Ehling, Roy A / Csepregi, Lucia / Kitamura, Daisuke / Reddy, Sai T

    Frontiers in immunology

    2019  Volume 10, Page(s) 2630

    Abstract: Immune cell therapies based on the integration of synthetic antigen receptors comprise a powerful strategy for the treatment of diverse diseases, most notably T cells engineered to express chimeric antigen receptors (CAR) for targeted cancer therapy. In ... ...

    Abstract Immune cell therapies based on the integration of synthetic antigen receptors comprise a powerful strategy for the treatment of diverse diseases, most notably T cells engineered to express chimeric antigen receptors (CAR) for targeted cancer therapy. In addition to T lymphocytes, B lymphocytes may also represent valuable immune cells that can be engineered for therapeutic purposes such as protein replacement therapy or recombinant antibody production. In this article, we report a promising concept for the molecular design, optimization, and genomic integration of a novel class of synthetic antigen receptors, chimeric B cell receptors (CBCR). We initially optimized CBCR expression and detection by modifying the extracellular surface tag, the transmembrane regions and intracellular signaling domains. For this purpose, we stably integrated a series of CBCR variants using CRISPR-Cas9 into immortalized B cell hybridomas. Subsequently, we developed a reliable and consistent pipeline to precisely introduce cassettes of several kb size into the genome of primary murine B cells also using CRISPR-Cas9 induced HDR. Finally, we were able to show the robust surface expression and antigen recognition of a synthetic CBCR in primary B cells. We anticipate CBCRs and our approach for engineering primary B cells will be a valuable tool for the advancement of future B cell- based immune cell therapies.
    MeSH term(s) Animals ; B-Lymphocytes ; CRISPR-Cas Systems ; Gene Editing/methods ; Mice ; Protein Engineering/methods ; Receptors, Antigen, B-Cell/genetics ; Receptors, Antigen, B-Cell/immunology ; Receptors, Artificial/genetics ; Receptors, Artificial/immunology
    Chemical Substances Receptors, Antigen, B-Cell ; Receptors, Artificial
    Language English
    Publishing date 2019-11-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2019.02630
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Antibody discovery and engineering by enhanced CRISPR-Cas9 integration of variable gene cassette libraries in mammalian cells.

    Parola, Cristina / Neumeier, Daniel / Friedensohn, Simon / Csepregi, Lucia / Di Tacchio, Mariangela / Mason, Derek M / Reddy, Sai T

    mAbs

    2019  Volume 11, Issue 8, Page(s) 1367–1380

    Abstract: Antibody engineering in mammalian cells offers the important advantage of expression and screening of libraries in their native conformation, increasing the likelihood of generating candidates with more favorable molecular properties. Major advances in ... ...

    Abstract Antibody engineering in mammalian cells offers the important advantage of expression and screening of libraries in their native conformation, increasing the likelihood of generating candidates with more favorable molecular properties. Major advances in cellular engineering enabled by CRISPR-Cas9 genome editing have made it possible to expand the use of mammalian cells in biotechnological applications. Here, we describe an antibody engineering and screening approach where complete variable light (V
    MeSH term(s) Animals ; Clustered Regularly Interspaced Short Palindromic Repeats ; Female ; Gene Editing ; Gene Library ; Hybridomas/metabolism ; Mice ; Mice, Inbred BALB C ; Single-Chain Antibodies/genetics ; Single-Chain Antibodies/metabolism
    Chemical Substances Single-Chain Antibodies
    Language English
    Publishing date 2019-09-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1942-0870
    ISSN (online) 1942-0870
    DOI 10.1080/19420862.2019.1662691
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single-cell analysis.

    Neumeier, Daniel / Pedrioli, Alessandro / Genovese, Alessandro / Sandu, Ioana / Ehling, Roy / Hong, Kai-Lin / Papadopoulou, Chrysa / Agrafiotis, Andreas / Kuhn, Raphael / Shlesinger, Danielle / Robbiani, Damiano / Han, Jiami / Hauri, Laura / Csepregi, Lucia / Greiff, Victor / Merkler, Doron / Reddy, Sai T / Oxenius, Annette / Yermanos, Alexander

    European journal of immunology

    2021  Volume 52, Issue 2, Page(s) 297–311

    Abstract: Plasma cells and their secreted antibodies play a central role in the long-term protection against chronic viral infection. However, due to experimental limitations, a comprehensive description of linked genotypic, phenotypic, and antibody repertoire ... ...

    Abstract Plasma cells and their secreted antibodies play a central role in the long-term protection against chronic viral infection. However, due to experimental limitations, a comprehensive description of linked genotypic, phenotypic, and antibody repertoire features of plasma cells (gene expression, clonal frequency, virus specificity, and affinity) has been challenging to obtain. To address this, we performed single-cell transcriptome and antibody repertoire sequencing of the murine BM plasma cell population following chronic lymphocytic choriomeningitis virus infection. Our single-cell sequencing approach recovered full-length and paired heavy- and light-chain sequence information for thousands of plasma cells and enabled us to perform recombinant antibody expression and specificity screening. Antibody repertoire analysis revealed that, relative to protein immunization, chronic infection led to increased levels of clonal expansion, class-switching, and somatic variants. Furthermore, antibodies from the highly expanded and class-switched (IgG) plasma cells were found to be specific for multiple viral antigens and a subset of clones exhibited cross-reactivity to nonviral and autoantigens. Integrating single-cell transcriptome data with antibody specificity suggested that plasma cell transcriptional phenotype was correlated to viral antigen specificity. Our findings demonstrate that chronic viral infection can induce and sustain plasma cell clonal expansion, combined with significant somatic hypermutation, and can generate cross-reactive antibodies.
    MeSH term(s) Animals ; Antibodies, Viral/genetics ; Antibodies, Viral/immunology ; Chronic Disease ; Clonal Selection, Antigen-Mediated ; Female ; Immunoglobulin Heavy Chains/genetics ; Immunoglobulin Heavy Chains/immunology ; Immunoglobulin Light Chains/genetics ; Immunoglobulin Light Chains/immunology ; Lymphocytic Choriomeningitis/genetics ; Lymphocytic Choriomeningitis/immunology ; Lymphocytic choriomeningitis virus/immunology ; Mice ; Plasma Cells/immunology ; Single-Cell Analysis
    Chemical Substances Antibodies, Viral ; Immunoglobulin Heavy Chains ; Immunoglobulin Light Chains
    Language English
    Publishing date 2021-11-23
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.202149331
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen.

    Sesterhenn, Fabian / Galloux, Marie / Vollers, Sabrina S / Csepregi, Lucia / Yang, Che / Descamps, Delphyne / Bonet, Jaume / Friedensohn, Simon / Gainza, Pablo / Corthésy, Patricia / Chen, Man / Rosset, Stéphane / Rameix-Welti, Marie-Anne / Éléouët, Jean-François / Reddy, Sai T / Graham, Barney S / Riffault, Sabine / Correia, Bruno E

    PLoS biology

    2019  Volume 17, Issue 2, Page(s) e3000164

    Abstract: Throughout the last several decades, vaccination has been key to prevent and eradicate infectious diseases. However, many pathogens (e.g., respiratory syncytial virus [RSV], influenza, dengue, and others) have resisted vaccine development efforts, ... ...

    Abstract Throughout the last several decades, vaccination has been key to prevent and eradicate infectious diseases. However, many pathogens (e.g., respiratory syncytial virus [RSV], influenza, dengue, and others) have resisted vaccine development efforts, largely because of the failure to induce potent antibody responses targeting conserved epitopes. Deep profiling of human B cells often reveals potent neutralizing antibodies that emerge from natural infection, but these specificities are generally subdominant (i.e., are present in low titers). A major challenge for next-generation vaccines is to overcome established immunodominance hierarchies and focus antibody responses on crucial neutralization epitopes. Here, we show that a computationally designed epitope-focused immunogen presenting a single RSV neutralization epitope elicits superior epitope-specific responses compared to the viral fusion protein. In addition, the epitope-focused immunogen efficiently boosts antibodies targeting the palivizumab epitope, resulting in enhanced neutralization. Overall, we show that epitope-focused immunogens can boost subdominant neutralizing antibody responses in vivo and reshape established antibody hierarchies.
    MeSH term(s) Animals ; Antibodies, Monoclonal, Humanized/chemistry ; Antibodies, Monoclonal, Humanized/immunology ; Antibodies, Neutralizing/biosynthesis ; Antibodies, Neutralizing/genetics ; Antibodies, Viral/biosynthesis ; Antibodies, Viral/genetics ; Cloning, Molecular ; Computer-Aided Design ; Epitopes/chemistry ; Epitopes/immunology ; Escherichia coli/genetics ; Escherichia coli/metabolism ; Female ; Gene Expression ; Genetic Vectors/chemistry ; Genetic Vectors/metabolism ; Immunization/methods ; Immunogenicity, Vaccine ; Mice ; Mice, Inbred BALB C ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Palivizumab/chemistry ; Palivizumab/immunology ; Receptors, Antigen, B-Cell/chemistry ; Receptors, Antigen, B-Cell/genetics ; Receptors, Antigen, B-Cell/immunology ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/chemistry ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/immunology ; Respiratory Syncytial Virus Vaccines/administration & dosage ; Respiratory Syncytial Virus Vaccines/biosynthesis ; Respiratory Syncytial Virus Vaccines/genetics ; Respiratory Syncytial Viruses/immunology ; Structural Homology, Protein ; Viral Fusion Proteins/administration & dosage ; Viral Fusion Proteins/chemistry ; Viral Fusion Proteins/genetics ; Viral Fusion Proteins/immunology
    Chemical Substances Antibodies, Monoclonal, Humanized ; Antibodies, Neutralizing ; Antibodies, Viral ; Epitopes ; Receptors, Antigen, B-Cell ; Recombinant Fusion Proteins ; Respiratory Syncytial Virus Vaccines ; Viral Fusion Proteins ; motavizumab (50Y163LK8Q) ; Palivizumab (DQ448MW7KS)
    Language English
    Publishing date 2019-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2126776-5
    ISSN 1545-7885 ; 1544-9173
    ISSN (online) 1545-7885
    ISSN 1544-9173
    DOI 10.1371/journal.pbio.3000164
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top